2CG Stock Overview
A nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
NanoSphere Health Sciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.007 |
| 52 Week High | CA$0.039 |
| 52 Week Low | CA$0.0005 |
| Beta | -0.21 |
| 11 Month Change | -30.00% |
| 3 Month Change | -65.00% |
| 1 Year Change | 1,300.00% |
| 33 Year Change | -92.39% |
| 5 Year Change | -99.33% |
| Change since IPO | -99.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2CG | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -41.7% | 1.6% | 1.1% |
| 1Y | 1,300.0% | -19.0% | 7.2% |
Return vs Industry: 2CG exceeded the German Pharmaceuticals industry which returned -19% over the past year.
Return vs Market: 2CG exceeded the German Market which returned 7.2% over the past year.
Price Volatility
| 2CG volatility | |
|---|---|
| 2CG Average Weekly Movement | 80.2% |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2CG's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 2CG's weekly volatility has decreased from 613% to 80% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | www.nanospherehealth.com |
NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in the bio delivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, and animal health industries. NanoSphere Health Sciences Inc. is headquartered in Vancouver, Canada.
NanoSphere Health Sciences Inc. Fundamentals Summary
| 2CG fundamental statistics | |
|---|---|
| Market cap | €243.13k |
| Earnings (TTM) | -€188.33k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.3x
P/E RatioIs 2CG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2CG income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$198.77k |
| Earnings | -US$198.76k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.019 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -1.9% |
How did 2CG perform over the long term?
See historical performance and comparison